查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2009178

數位病理市場規模、佔有率、趨勢和預測：按產品、產品類型、交付模式、最終用戶、應用和地區分類（2026-2034 年）

Digital Pathology Market Size, Share, Trends and Forecast by Product, Type, Delivery Model, End-User, Application, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2025年全球數位病理市場規模為11.095億美元，預計到2034年將達到23.531億美元，2026年至2034年的複合年成長率（CAGR）為8.28%。目前，北美市場佔據主導地位，預計到2025年將佔據超過40.7%的市場。推動該市場成長的主要因素是：隨著全球慢性病盛行率的上升，人們對能夠提高診斷準確性和簡化工作流程的先進診斷工具的需求激增。此外，技術突破、醫療數位化進程的推進以及有利的法規結構也進一步促進了市場成長，並擴大了全球數位病理市場佔有率。

數位病理市場的發展動力源於對先進診斷工具日益成長的需求以及癌症等慢性疾病發病率的上升。人工智慧 (AI) 和機器學習的整合正在提高診斷準確性並簡化病理學家的工作流程。例如，2024 年 9 月，羅氏擴展了其“數位病理開放環境”，整合了來自八家合作夥伴的 20 多種 AI 演算法，以改進癌症診斷。該計畫旨在支持臨床醫生進行精準醫療，透過標靶治療改善患者預後，並利用先進技術革新癌症研究，實現精準診斷和個人化醫療。醫療保健的數位化以及對遠距病理診斷解決方案投資的增加，推動了遠距醫療和第二意見的普及，進一步促進了市場應用。數位系統的監管核准以及向個人化醫療的轉變也是關鍵因素。影像技術和雲端資料儲存解決方案的進步提升了擴充性，提高了可存取性，並使數位病理成為現代醫療保健基礎設施的重要組成部分。

美國數位病理市場的發展主要得益於精準醫療的日益普及和醫療技術的進步。人工智慧（AI）在影像分析領域的應用不斷拓展，提高了診斷效率和準確性，滿足了人們對高品質患者照護日益成長的需求。癌症等慢性疾病發生率的上升也推動了對先進病理解決方案的需求。根據美國國家癌症研究所發布的數據，預計到2024年，美國將新增2,001,140例癌症病例，並有611,720例癌症相關死亡病例。攝護腺癌、肺癌和大腸癌預計將佔男性癌症診斷總數的48%，而乳癌、肺癌和大腸癌預計將佔女性癌症診斷總數的51%。癌症發生率為每10萬人440.5例，死亡率為每10萬人146例。政府措施和有利的法規結構正在加速數位化平台的普及，包括用於遠距會診的遠距病理學。雲端儲存解決方案的整合實現了無縫的資料共用和擴充性，隨著美國在醫療保健和研究數位化的大量投資，進一步推動了市場在美國的擴張。

數位病理學市場的發展趨勢：

技術進步

成像技術、軟體開發和整合能力的持續創新發揮著至關重要的作用。先進的成像技術提供高解析度影像，這對於精準診斷至關重要；而利用人工智慧 (AI) 和機器學習 (ML) 的複雜演算法則能提高診斷準確率、自動化繁瑣任務並實現預測分析。報告顯示，人工智慧在醫學診斷領域的應用可望將治療效果提升 40%，並將治療成本降低 50%。這些進步使得患者診斷和預後評估更加快速且準確，支援遠距醫療，並能夠儲存和管理大量數據，從而加速這些系統在全球範圍內的普及。將這些技術與電子健康記錄(EMR) 和實驗室資訊系統 (LIS) 整合，可簡化工作流程、提高臨床效率、促進醫療保健領域的協作，並進一步推動數位病理市場的成長。 Proscia、PathAI、Ibex Medical Analytics、Paige 和 Clarapath 等領先企業在技術進步、建立協作式醫療保健生態系統以及推動數位病理的全球應用方面發揮了至關重要的作用。

慢性病盛行率增加

隨著癌症等慢性疾病在全球範圍內的日益增多，對更有效率的診斷解決方案的需求也日益迫切，而數位病理學已成為現代醫學中不可或缺的工具。根據美國國家醫學圖書館統計，慢性疾病在全球範圍內的持續成長令人擔憂，2019年慢性疾病導致的死亡人數佔所有死亡人數的74%，較2010年的67%顯著上升。數位病理學使病理學家能夠比傳統顯微鏡更快、更準確地分析和解讀數位切片，從而加快診斷流程並改善患者預後。遠距病理學支援高級組織分析，能夠進行詳細的檢查並輔助識別疾病標記物，這對於個人化醫療和標靶治療至關重要。此外，遠距病理學能夠高效處理大量病例，有效緩解病理檢查室日益繁重的工作量，並支持快速準確的診斷，而這對於有效的疾病管理和治療方案的製定至關重要。正因如此，遠程病理學在對抗慢性疾病的鬥爭中發揮著不可或缺的作用。

遠距病理診斷的需求日益成長

遠距離診斷的需求比以往任何時候都更加迫切，尤其是在全球健康面臨挑戰的當下。遠端病理學使病理學家能夠不受地理限制地檢查和共用高品質的數位切片，從而確保病理診斷服務的連續性。這在醫療資源匱乏的地區尤其重要，它能夠提供專家會診和第二意見，從而提高診斷的準確性。遠距病理學彌合了城鄉醫療設施之間的差距，使優質醫療服務的可及性更加均衡，並促進了更協作、高效和有效的醫療生態系統的發展。例如，世界衛生組織預測，到2030年，全球將出現1,000萬醫護人員的缺口，尤其是在低收入和中低收入國家，這催生了對遠距病理學等創新解決方案的需求。數位系統的擴充性使其能夠處理越來越多的切片，滿足日益成長的診斷需求，同時促進更一體化和以患者為中心的醫療解決方案的發展。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球數位病理市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 掃描器
  • 軟體
  • 儲存系統
  • 通訊系統

第7章 市場區隔：依類型

  • 人類病理學
  • 獸醫病理學

第8章 市場區隔：依產品/服務模式分類

  • 現場
  • 託管

第9章 市場區隔：依應用領域分類

  • 培訓和教育
  • 諮詢服務
  • 術中會診
  • 日常診斷與諮詢服務
  • 其他

第10章 市場區隔：依最終用戶分類

  • 製藥和生物技術公司
  • 醫院和檢測機構
  • 學術研究機構

第11章 市場區隔：按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 伊朗
    • 阿拉伯聯合大公國
    • 其他

第12章 SWOT 分析

第13章：價值鏈分析

第14章：波特五力分析

第15章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • DHISTECH
    • Apollo Enterprise Imaging
    • Corista
    • Hamamatsu Photonics
    • Huron Digital Pathology
    • Indica Labs
    • Koninklijke Philips
    • Leica Biosystems
    • Objective Pathology Services
    • Ventana Medical Systems
    • Visiopharm
    • XIFIN
Product Code: SR112026A1836

The global digital pathology market size was valued at USD 1,109.5 Million in 2025. Looking forward, the market is projected to reach USD 2,353.1 Million by 2034, exhibiting a CAGR of 8.28% during 2026-2034. North America currently dominates the market, holding a significant market share of over 40.7% in 2025. The market is driven by the surging demand for advanced diagnostic tools that enhance accuracy and streamline workflows amid rising chronic disease prevalence worldwide. Additionally, technological breakthroughs, increased healthcare digitization and supportive regulatory frameworks propel market growth, further augmenting the global digital pathology market share.

The digital pathology market is driven by the rising demand for advanced diagnostic tools and the heightened incidence of chronic diseases such as cancer. The integration of artificial intelligence and machine learning enhances diagnostic accuracy and streamlining workflows for pathologists. For instance, in September 2024, Roche expanded its Digital Pathology Open Environment by incorporating more than 20 AI algorithms from eight partners, aimed at improving cancer diagnostics. This initiative aims to support clinicians in precision medicine improving patient outcomes through targeted treatments and revolutionizing cancer research with advanced technology for accurate diagnosis and personalized healthcare. Growing investments in healthcare digitization and telepathology solutions further boost market adoption enabling remote consultations and second opinions. Regulatory approvals for digital systems and the shift toward personalized medicine are also significant factors. Advancements in imaging technologies and cloud-based data storage solutions support scalability and improve accessibility making digital pathology a critical component of modern healthcare infrastructure.

The United States digital pathology market is driven by a rising focus on precision medicine and advancements in healthcare technologies. Increasing adoption of artificial intelligence for image analysis enhances diagnostic efficiency and accuracy meeting the growing demand for high-quality patient care. The rising incidence of chronic diseases, such as cancer, drives the demand for advanced pathology solutions. According to data published by the National Cancer Institute, in 2024, the U.S. is projected to have 2,001,140 new cancer cases and 611,720 cancer-related deaths. Prostate, lung and colorectal cancers will account for 48% of diagnoses in men while breast, lung and colorectal cancers will make up 51% in women. The cancer incidence rate is 440.5 per 100,000 people, with a mortality rate of 146.0. Government initiatives and favorable regulatory frameworks accelerate the adoption of digital platforms including telepathology for remote consultations. The integration of cloud-based storage solutions enables seamless data sharing and scalability while significant investments in healthcare digitization and research further support the market's expansion across the country.

DIGITAL PATHOLOGY MARKET TRENDS:

Technological advancements

The relentless pace of innovation in imaging techniques, software development and integration capabilities has been pivotal. Enhanced imaging technologies offer high-resolution images essential for accurate diagnosis while sophisticated algorithms powered by artificial intelligence (AI) and machine learning (ML) improve diagnostic precision, automate tedious tasks and enable predictive analytics. According to reports, AI in medical diagnosis has the potential to improve health outcomes by 40% and lower treatment costs by 50%.These advancements facilitate faster and more accurate patient diagnoses and prognoses which in turn support remote consultations and enable vast data storage and management thus driving the adoption of this systems globally. The integration of this with electronic medical records (EMRs) and laboratory information systems (LIS) streamlines workflows, enhances clinical efficiency, and fosters a more collaborative approach to healthcare further propelling the digital pathology market growth. Some of the key players include Proscia, PathAI, Ibex Medical Analytics, Paige, and Clarapath, who have been instrumental in advancing these technologies, fostering collaborative healthcare ecosystems and accelerating the adoption of digital pathology globally.

Increasing prevalence of chronic diseases

The global increase in chronic illnesses such as cancer demands more efficient diagnostic solutions, positioning it as a crucial tool in modern healthcare. According to National Library of Medicine, the global rise in chronic illnesses, responsible for 74% of all deaths in 2019, highlights an alarming increase from 67% in 2010. It enables pathologists to analyze and interpret digital slides with greater speed and precision compared to traditional microscopy, thereby accelerating the diagnostic process and improving patient outcomes. It supports advanced tissue analysis, enabling detailed examination and aiding in the identification of disease markers, which is vital for personalized medicine and targeted therapies. Its capacity for managing large volumes of cases effectively addresses the growing workload in pathology labs, thereby supporting the rapid and accurate diagnosis necessary for effective disease management and treatment planning, making it indispensable in the fight against chronic diseases.

Growing demand for telepathology

The need for remote diagnostics has never been more pronounced, especially in the wake of global health challenges. It facilitates telepathology, allowing pathologists to examine and share high-quality digital slides irrespective of geographical constraints, thus ensuring uninterrupted pathology services. This is particularly advantageous for regions with limited access to specialized healthcare services, enabling expert consultation and second opinions that enhance diagnostic accuracy. Telepathology bridges the gap between rural and urban healthcare facilities, democratizing access to high-quality medical services and fostering a more collaborative, efficient, and effective healthcare ecosystem. For instance, WHO projects a shortage of 10 Million health workers by 2030, particularly in low- and lower-middle-income countries creating demand for innovative solution like telepathology. The scalability of digital systems allows for the handling of increasing slide volumes, catering to growing diagnostic demands while promoting more integrated and patient-centric healthcare solutions.

DIGITAL PATHOLOGY INDUSTRY SEGMENTATION:

Analysis by Product:

  • Scanners
  • Software
  • Storage Systems
  • Communication Systems

Scanners leads the market due to their critical role in digitizing histopathological slides for analysis, storage, and sharing. These devices range from high-throughput models designed for large laboratories to more compact versions for smaller settings, all aiming to deliver high-resolution images that retain the nuances of traditional microscopy. The advancement in scanning technologies has significantly reduced the time and cost per slide, enabling a seamless transition from analog to digital formats. This shift is instrumental in accommodating the growing volume of pathology samples, driven by an increase in cancer cases and other chronic diseases that necessitate detailed tissue analysis. Furthermore, the integration of scanners with AI and ML algorithms has facilitated new methods for automated image analysis, increasing diagnostic precision and effectiveness. As the cornerstone of this, scanners continue to improve, incorporating faster scanning speeds, higher image resolutions, and improved usability, ensuring their dominance in the market.

Analysis by Type:

  • Human Pathology
  • Veterinary Pathology

Human Pathology leads the market with around 62.2% of digital pathology market share in 2025. Human pathology plays a pivotal role in modern healthcare by enabling the detailed examination and analysis of human tissue samples. This segment has gained substantial momentum due to its crucial role in diagnosing a wide array of human diseases, especially cancer, where precision and timely diagnosis are vital. The integration of advanced imaging technologies, AI, and machine learning algorithms has significantly enhanced the accuracy, efficiency, and speed of pathological analysis, leading to improved patient outcomes. These technologies facilitate the detailed examination of slides, enabling pathologists to detect diseases at earlier stages and with greater precision. Furthermore, human pathology benefits immensely from digital archiving, which improves data retrieval and sharing, supporting collaborative diagnostics and research globally. The ability to quickly share high-resolution images across locations has also been instrumental in advancing telepathology, making specialized diagnostic expertise more accessible and facilitating second opinions, thereby enhancing the quality of care and patient management.

Analysis by Delivery Model:

  • On-premises
  • Hosted

The on-premises delivery model offers substantial control over the infrastructure and data, a critical factor for many healthcare organizations. This model involves the installation of software and hardware within the premises of the organization, ensuring robust data security and privacy, as it allows sensitive patient data to remain within the institution's firewall. It is particularly favored by large healthcare institutions and research facilities that prioritize data control, require high-speed access to large image files, and can afford the significant upfront investment in infrastructure. The on-premises model also facilitates compliance with stringent regulatory standards, as healthcare providers can directly oversee the management and security of the data.

Analysis by Application:

  • Training and Education
  • Consulting Services
  • Intraoperative Consultation
  • Routine Diagnostic Consultation Services
  • Others

Routine diagnostic consultation services represent the core application of this in everyday healthcare practices. This segment encompasses the use of this is for standard diagnostic evaluations, where pathologists review digitized slide images to detect, diagnose, and provide prognostic information on various diseases, primarily cancer. The integration of this in routine diagnostics significantly enhances the efficiency, accuracy, and speed of diagnostic processes. It allows for the storage of vast amounts of digital slides and associated data, facilitating easier data retrieval, long-term case study, and educational use. The technology's ability to enable quick sharing of digital slides and collaborative diagnostics also supports multi-disciplinary team meetings, ensuring comprehensive patient care.

Analysis by End-User:

  • Pharmaceutical & Biotechnology Companies
  • Hospitals and Reference Laboratories
  • Academic & Research Institutes

Academic and research institutes leads the market with around 45.7% of market share in 2025. Academic and research institutes represent the education, research, and diagnostic applications. The adoption of this in these institutes facilitates comprehensive educational programs, allowing students and trainees to access a wealth of digital slides and participate in interactive learning environments. It significantly enhances research capabilities, providing researchers with the tools to perform detailed morphological analyses, quantitative assessments, and high-throughput image analysis. This is crucial for advancing our understanding of disease pathology, developing novel therapeutic strategies, and contributing to the body of scientific knowledge.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Others
  • Middle East and Africa
    • Turkey
    • Saudi Arabia
    • Iran
    • United Arab Emirates
    • Others

In 2025, North America accounted for the largest market share of over 40.7%. North America region boasts high-tech healthcare infrastructure, high adoption of digital imaging solutions, and significant investments in healthcare IT. The presence of prominent market players who consistently innovate in AI and machine learning technologies drives the dynamic growth of this sector. Furthermore, the region's strong emphasis on cancer research, coupled with substantial funding for oncology studies, propels the demand for this is to enable quick, accurate diagnoses and research applications. Regulatory support from bodies like the FDA, which has been progressively approving this system for diagnostic use, also plays a crucial role.. Additionally, the increasing shift towards personalized medicine in North America requires comprehensive tissue analyses, thereby driving the adoption of these solutions.

KEY REGIONAL TAKEAWAYS:

UNITED STATES DIGITAL PATHOLOGY MARKET ANALYSIS

In 2025, United States accounted for a share of 89.80% of the North America market. In the United States the adoption of digital pathology is significantly influenced by the expansion of sophisticated healthcare systems. As healthcare infrastructure evolves with cutting-edge technologies such as advanced imaging and data analytics there is an increasing shift towards incorporating digital pathology for more efficient diagnostic processes. For instance, venture-capital investments in health AI in the United States are set to hit USD 11 Billion this year fuelling advancements in healthcare infrastructure. These developments are pivotal for enhancing digital pathology modifying diagnostic capabilities and workflow efficiency. The integration of high-performance computing, cloud-based systems and artificial intelligence further enhances the ability to store, analyze and share pathology data promoting collaboration and improving diagnostic accuracy. These developments foster an environment where healthcare providers can better manage and interpret vast volumes of patient data, driving faster and more precise diagnoses. Additionally, healthcare institutions are continuously expanding their capabilities with state-of-the-art equipment reinforcing the trend toward digital pathology as an essential tool for enhancing diagnostic workflows.

ASIA PACIFIC DIGITAL PATHOLOGY MARKET ANALYSIS

In the Asia-Pacific region the ongoing digital transformation in the healthcare sector plays a pivotal role in the rise of digital pathology adoption. According to reports, 79% of innovations among Indian MedTech start-ups focus on medical technology solutions with 63% integrating digital advancements. This growing trend is particularly beneficial for Digital Pathology enhancing diagnostic precision and accessibility. Governments and private healthcare providers are increasingly focusing on incorporating digital tools aiming to streamline medical processes, reduce costs and improve the quality of care. As healthcare systems modernize and adopt more electronic health records, imaging technologies and telemedicine services the transition to digital pathology becomes more seamless. Moreover, the growing emphasis on healthcare accessibility and affordability encourages the integration of digital pathology solutions to bridge gaps in medical services especially in rural and underserved areas leading to better patient outcomes.

EUROPE DIGITAL PATHOLOGY MARKET ANALYSIS

In Europe, the growing prevalence of chronic illnesses is a key driver in the increased adoption of digital pathology. As the region faces a rising burden of conditions such as cancer, cardiovascular diseases and diabetes there is a significant demand for more precise and timely diagnostic tools. For instance, in the UK, 395,181 cancer cases were diagnosed in 2021 highlighting the increasing demand for advanced diagnostic tools. This growing trend is driving the adoption of digital pathology offering more efficient and accurate cancer detection. Digital pathology enables the use of advanced imaging techniques and data-driven insights allowing for more accurate detection and personalized treatment plans. With the need for improved diagnostic efficiency in managing chronic diseases healthcare providers are increasingly turning to digital pathology to enhance workflow, reduce errors and expedite diagnosis resulting in better management of these long-term health conditions.

LATIN AMERICA DIGITAL PATHOLOGY MARKET ANALYSIS

In Latin America, the increasing availability of disposable income among the population is accelerating the adoption of digital pathology. For instance, total disposable income in Latin America is projected to grow by nearly 60% from 2021 to 2040 driven by regional equality, technological progress and sectoral shifts benefiting the expansion of digital healthcare services. As individuals in the region experience rising economic prosperity there is a greater ability to access advanced healthcare services including digital diagnostic tools. Healthcare institutions are upgrading their facilities to include digital pathology solutions offering enhanced precision and efficiency in diagnoses. This financial growth supports the widespread implementation of digital solutions in medical practices allowing patients to benefit from quicker more accurate diagnostic results and fostering a healthier population overall.

MIDDLE EAST AND AFRICA DIGITAL PATHOLOGY MARKET ANALYSIS

In the Middle East and Africa, the development of healthcare infrastructure is promoting the widespread adoption of digital pathology technologies . According to Dubai Healthcare City Authority report, by 2022, Dubai saw 4,482 private medical facilities including 56 hospitals and 55,208 licensed medical professionals. The projected 10-15% growth in medical professionals and 3-6% increase in facilities will enhance the adoption of digital pathology improving healthcare services and diagnostic capabilities. As healthcare infrastructure continues to grow in these regions particularly in urban areas there is an increasing integration of advanced diagnostic tools to meet the rising demand for high-quality medical care. With a focus on modernizing hospitals and medical centres there is greater investment in digital pathology systems that can enhance the speed, accuracy and collaboration in diagnosing a wide range of diseases. The improved access to state-of-the-art healthcare facilities makes digital pathology more accessible and increasingly prevalent benefiting both patients and healthcare providers.

COMPETITIVE LANDSCAPE:

The digital pathology market is marked by intense competition driven by technological advancements and the growing adoption of AI-powered diagnostic tools. Companies focus on enhancing image analysis, data integration and cloud-based solutions to streamline pathology workflows and improve diagnostic accuracy. The market sees strong collaboration between technology providers, healthcare institutions and research organizations to develop scalable and interoperable systems. For instance, in July 2024, AGFA HealthCare launched its integrated solution Enterprise Imaging for Pathology powered by Corista DP3 in North America. Designed by pathologists for pathologists it enhances digital workflow, efficiency, data management and collaboration addressing the transition from analog to digital pathology. Increasing demand for telepathology and remote consultation capabilities further fuels innovation. Regulatory approvals and conformity with healthcare standards play a key role in enabling market players to obtain a competitive advantage.. The push for personalized medicine and improved patient outcomes motivates continuous research and development positioning digital pathology as a vital component in modern diagnostics and healthcare infrastructure.

The report provides a comprehensive analysis of the competitive landscape in the digital pathology market with detailed profiles of all major companies, including:

  • DHISTECH
  • Apollo Enterprise Imaging
  • Corista
  • Hamamatsu Photonics
  • Huron Digital Pathology
  • Indica Labs
  • Koninklijke Philips
  • Leica Biosystems
  • Objective Pathology Services
  • Ventana Medical Systems
  • Visiopharm
  • XIFIN

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the global digital pathology market?

2. What is the expected growth rate of the global digital pathology market during 2026-2034?

3. What are the key factors driving the global digital pathology market?

4. What is the leading segment of the global digital pathology market based on product?

5. Who are the key players/companies in the global digital pathology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Digital Pathology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Scanners
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Software
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Storage Systems
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Communication Systems
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Human Pathology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Veterinary Pathology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Delivery Model

  • 8.1 On-premises
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hosted
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Training and Education
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Consulting Services
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Intraoperative Consultation
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Routine Diagnostic Consultation Services
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Pharmaceutical & Biotechnology Companies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals and Reference Laboratories
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Academic & Research Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Germany
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 France
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 United Kingdom
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 Italy
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Spain
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Russia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 China
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 Japan
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 India
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 South Korea
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Australia
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Indonesia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Argentina
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
    • 11.4.4 Colombia
      • 11.4.4.1 Market Trends
      • 11.4.4.2 Market Forecast
    • 11.4.5 Chile
      • 11.4.5.1 Market Trends
      • 11.4.5.2 Market Forecast
    • 11.4.6 Peru
      • 11.4.6.1 Market Trends
      • 11.4.6.2 Market Forecast
    • 11.4.7 Others
      • 11.4.7.1 Market Trends
      • 11.4.7.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Turkey
      • 11.5.1.1 Market Trends
      • 11.5.1.2 Market Forecast
    • 11.5.2 Saudi Arabia
      • 11.5.2.1 Market Trends
      • 11.5.2.2 Market Forecast
    • 11.5.3 Iran
      • 11.5.3.1 Market Trends
      • 11.5.3.2 Market Forecast
    • 11.5.4 United Arab Emirates
      • 11.5.4.1 Market Trends
      • 11.5.4.2 Market Forecast
    • 11.5.5 Others
      • 11.5.5.1 Market Trends
      • 11.5.5.2 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 DHISTECH
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Apollo Enterprise Imaging
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Corista
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Hamamatsu Photonics
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Huron Digital Pathology
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Indica Labs
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Koninklijke Philips
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Leica Biosystems
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Objective Pathology Services
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Ventana Medical Systems
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Visiopharm
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 XIFIN
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Digital Pathology Market: Major Drivers and Challenges
  • Figure 2: Global: Digital Pathology Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Digital Pathology Market: Breakup by Product (in %), 2025
  • Figure 4: Global: Digital Pathology Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Digital Pathology Market: Breakup by Delivery Model (in %), 2025
  • Figure 6: Global: Digital Pathology Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Digital Pathology Market: Breakup by End-User (in %), 2025
  • Figure 8: Global: Digital Pathology Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Digital Pathology (Scanners) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Digital Pathology (Scanners) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Digital Pathology (Software) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Digital Pathology (Software) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Digital Pathology (Storage Systems) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Digital Pathology (Storage Systems) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Digital Pathology (Communication Systems) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Digital Pathology (Communication Systems) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Digital Pathology (Human Pathology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Digital Pathology (Human Pathology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Digital Pathology (Veterinary Pathology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Digital Pathology (Veterinary Pathology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Digital Pathology (On-premises) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Digital Pathology (On-premises) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Digital Pathology (Hosted) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Digital Pathology (Hosted) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Digital Pathology (Training and Education) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Digital Pathology (Training and Education) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Digital Pathology (Consulting Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Digital Pathology (Consulting Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Digital Pathology (Intraoperative Consultation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Digital Pathology (Intraoperative Consultation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Digital Pathology (Routine Diagnostic Consultation Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Digital Pathology (Routine Diagnostic Consultation Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Digital Pathology (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Digital Pathology (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Digital Pathology (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Digital Pathology (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Digital Pathology (Hospitals and Reference Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Digital Pathology (Hospitals and Reference Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Global: Digital Pathology (Academic & Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Global: Digital Pathology (Academic & Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: North America: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: North America: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: United States: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: United States: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Canada: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Canada: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Europe: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Europe: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Germany: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Germany: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: France: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: France: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: United Kingdom: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: United Kingdom: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Italy: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Italy: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Spain: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Spain: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Russia: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Russia: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Others: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Others: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Asia Pacific: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Asia Pacific: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: China: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: China: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Japan: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Japan: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: India: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: India: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: South Korea: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: South Korea: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Australia: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Australia: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Indonesia: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Indonesia: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Others: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Others: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Latin America: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Latin America: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Brazil: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Brazil: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Mexico: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Mexico: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Argentina: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Argentina: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Colombia: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 89: Colombia: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 90: Chile: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 91: Chile: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 92: Peru: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 93: Peru: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 94: Others: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 95: Others: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 96: Middle East and Africa: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 97: Middle East and Africa: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 98: Turkey: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 99: Turkey: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 100: Saudi Arabia: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 101: Saudi Arabia: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 102: Iran: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 103: Iran: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 104: United Arab Emirates: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 105: United Arab Emirates: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 106: Others: Digital Pathology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 107: Others: Digital Pathology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 108: Global: Digital Pathology Industry: SWOT Analysis
  • Figure 109: Global: Digital Pathology Industry: Value Chain Analysis
  • Figure 110: Global: Digital Pathology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Digital Pathology Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Digital Pathology Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Digital Pathology Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 4: Global: Digital Pathology Market Forecast: Breakup by Delivery Model (in Million USD), 2026-2034
  • Table 5: Global: Digital Pathology Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 6: Global: Digital Pathology Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 7: Global: Digital Pathology Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 8: Global: Digital Pathology Market Structure
  • Table 9: Global: Digital Pathology Market: Key Players